• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION SMART CONTROL, ILIAC 6X60ML; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION SMART CONTROL, ILIAC 6X60ML; STENT, ILIAC Back to Search Results
Catalog Number C06060ML
Device Problems Material Frayed (1262); Torn Material (3024)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/09/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).This device is not available for testing and evaluation.Additional information is pending and will be submitted within 30 days upon receipt.A review of the manufacturing documentation associated with this lot 17587435 presented no issues during the manufacturing process that can be related to the reported complaint.
 
Event Description
A balloon catheter (3 mm*10 cm) inflated in the lesion as a pre-dilatation, and a smart control, iliac 6 x 60 ml stent was inserted.However there was resistance felt during delivery and removed.Then the distal tip was confirmed to be frayed.Therefore it was replaced with a new smart control.The procedure completed successfully.There was no reported patient injury.The product was clinically used and it will not be returned for analysis.The target lesion was the right superficial femoral artery.The patient¿s vessel level of tortuousness, calcification and rate of stenosis was unknown.Additional information was requested.
 
Manufacturer Narrative
The sections have been updated accordingly.During an endovascular interventional procedure, a balloon catheter was inflated in the lesion as a pre-dilatation.A smart control iliac 6 x 60 ml stent was inserted to the lesion.There was resistance felt during delivery and the stent was not deployed.The stent delivery system was removed.Upon examination of the system, the distal tip was confirmed to be frayed.It was replaced with a new smart control.The procedure completed successfully.There was no reported patient injury.The product was clinically used and it will not be returned for analysis.The target lesion was the right superficial femoral artery.The patient¿s vessel level of tortuousness, calcification and rate of stenosis was unknown.The product was properly inspected and prepped prior to use.The device was prepared as specified by the instructions for use.There was no apparent damage to the device noticed prior to use.The physician was able to get the guidewire through the guiding catheter during the procedure.Difficulty was encountered while advancing/tracking the device towards the lesion.The access site was the left femoral artery and a contralateral approach was used.Additional procedural details were requested but are unknown.The product was not returned for analysis.A device history record (dhr) review of lot 17587435 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported stent delivery system- resistance/friction-outer sheath and distal tip- frayed/split/torn could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.Although the vessel characteristics are unknown, characteristics of tortuosity, calcification and rate of stenosis may have contributed to the reported event.According to the instructions for use ¿after careful inspection of the pouch looking for damage to the sterile barrier, carefully peel open the pouch and extract the stent delivery system from the tray.Examine the device for any damage.If it is suspected that the sterility or performance of the device has been compromised, the device should not be used.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Advance the device over the guidewire through the hemostatic valve and sheath introducer.Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.¿ neither the dhr nor the information available suggests a design or manufacturing related cause for the reported burst; therefore, no corrective/preventive action will be taken.
 
Event Description
A balloon catheter (3 mm*10 cm) inflated in the lesion as a pre-dilatation, and a smart control, iliac 6 x 60 ml stent was inserted.However there was resistance felt during delivery and removed.Then the distal tip was confirmed to be frayed.Therefore it was replaced with a new smart control.The procedure completed successfully.There was no reported patient injury.The product was clinically used and it will not be returned for analysis.The target lesion was the right superficial femoral artery.The patient¿s vessel level of tortuousness, calcification and rate of stenosis was unknown.The product was properly inspected and prepped prior to use.The device was prepared as specified by the instructions for use.There were no apparent damage to the device noticed prior to use.The physician was able to get the guidewire through the gc during the procedure.Difficulty was encountered while advancing/tracking the device towards the lesion.The access site was the left femoral artery and a contralateral approach was used.Additional procedural details were requested but are unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART CONTROL, ILIAC 6X60ML
Type of Device
STENT, ILIAC
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
14201 nw 60th ave
miami lakes, FL 33014
MDR Report Key7084281
MDR Text Key93887127
Report Number9616099-2017-01656
Device Sequence Number1
Product Code NIO
UDI-Device Identifier20705032023532
UDI-Public20705032023532
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P020036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 01/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/05/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2018
Device Catalogue NumberC06060ML
Device Lot Number17587435
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/20/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-